Cargando…
The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors
Effective cancer therapeutics for brain tumors must be able to cross the blood-brain barrier (BBB) to reach the tumor in adequate quantities and overcome the resistance conferred by the local tumor microenvironment. Clinically approved chemotherapeutic agents have been investigated for brain neoplas...
Autores principales: | Cooper, Elizabeth, Choi, Peter J., Denny, William A., Jose, Jiney, Dragunow, Mike, Park, Thomas I.-H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204086/ https://www.ncbi.nlm.nih.gov/pubmed/34141613 http://dx.doi.org/10.3389/fonc.2021.654921 |
Ejemplares similares
-
Heptamethine Cyanine Dyes in the Design of Photoactive
Carbon Nanomaterials
por: Rodríguez-Pérez, Laura, et al.
Publicado: (2017) -
Site-Specific Labeling of Proteins with Near-IR Heptamethine Cyanine Dyes
por: Lin, Chen-Ming, et al.
Publicado: (2018) -
NIRF Heptamethine Cyanine Dye Nanocomplexes for Multi Modal Theranosis of Tumors
por: Thomas, Reju George, et al.
Publicado: (2017) -
Synthesis of Near-Infrared-Absorbing Anionic Heptamethine Cyanine Dyes with Trifluoromethyl Groups
por: Masuoka, Hiroki, et al.
Publicado: (2023) -
Heptamethine Cyanine–Based Application for Cancer Theranostics
por: Zhang, Lei, et al.
Publicado: (2022)